Suppr超能文献

过氧化物酶体增殖物激活受体通过与维甲酸X受体竞争介导与甲状腺激素受体的相互作用。亮氨酸拉链样七肽重复序列的可能作用。

Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.

作者信息

Juge-Aubry C E, Gorla-Bajszczak A, Pernin A, Lemberger T, Wahli W, Burger A G, Meier C A

机构信息

Thyroid Unit, University Hospital of Geneva, Switzerland.

出版信息

J Biol Chem. 1995 Jul 28;270(30):18117-22. doi: 10.1074/jbc.270.30.18117.

Abstract

The peroxisome proliferator-activated receptors (PPAR) and thyroid hormone receptors (TR) are members of the nuclear receptor superfamily, which regulate lipid metabolism and tissue differentiation. In order to bind to DNA and activate transcription, PPAR requires the formation of heterodimers with the retinoid X receptor (RXR). In addition to activating transcription through its own response elements, PPAR is able to selectively down-regulate the transcriptional activity of TR, but not vitamin D receptor. The molecular basis of this functional interaction has not been fully elucidated. By means of site-directed mutagenesis of hPPAR alpha we mapped its inhibitory action on TR to a leucine zipper-like motif in the ligand binding domain of PPAR, which is highly conserved among all subtypes of this receptor and mediates heterodimerization with RXR. Replacement of a single leucine by arginine at position 433 of hPPAR alpha (L433R) abolished heterodimerization of PPAR with RXR and consequently its trans-activating capacity. However, a similar mutation of a leucine residue to arginine at position 422 showed no alteration of heterodimerization, DNA binding, or transcriptional activation. The dimerization deficient mutant L433R was no longer able to inhibit TR action, demonstrating that the selective inhibitory effect of PPAR results from the competition for RXR as well as possibly for other TR-auxiliary proteins. In contrast, abolition of DNA binding by a mutation in the P-box of PPAR (C122S) did not eliminate the inhibition of TR trans-activation, indicating that competition for DNA binding is not involved. Additionally, no evidence for the formation of PPAR:TR heterodimers was found in co-immunoprecipitation experiments. In summary, we have demonstrated that PPAR selectively inhibits the transcriptional activity of TRs by competition for RXR and possibly non-RXR TR-auxiliary proteins. In contrast, this functional interaction is independent of the formation of PPAR:TR heterodimers or competition for DNA binding.

摘要

过氧化物酶体增殖物激活受体(PPAR)和甲状腺激素受体(TR)是核受体超家族的成员,它们调节脂质代谢和组织分化。为了结合DNA并激活转录,PPAR需要与视黄酸X受体(RXR)形成异二聚体。除了通过自身的反应元件激活转录外,PPAR还能够选择性地下调TR的转录活性,但对维生素D受体则无此作用。这种功能相互作用的分子基础尚未完全阐明。通过对人PPARα进行定点诱变,我们将其对TR的抑制作用定位到PPAR配体结合域中的一个亮氨酸拉链样基序上,该基序在该受体的所有亚型中高度保守,并介导与RXR的异二聚化。将人PPARα第433位的单个亮氨酸替换为精氨酸(L433R)消除了PPAR与RXR的异二聚化,从而使其反式激活能力丧失。然而,在第422位将一个亮氨酸残基突变为精氨酸的类似突变并未显示异二聚化、DNA结合或转录激活有改变。缺乏二聚化能力的突变体L433R不再能够抑制TR的作用,这表明PPAR的选择性抑制作用源于对RXR以及可能对其他TR辅助蛋白的竞争。相反,通过PPAR的P盒突变(C122S)消除DNA结合并未消除对TR反式激活的抑制,这表明不涉及对DNA结合的竞争。此外,在共免疫沉淀实验中未发现形成PPAR:TR异二聚体的证据。总之,我们已经证明PPAR通过竞争RXR以及可能的非RXR TR辅助蛋白来选择性抑制TR的转录活性。相反,这种功能相互作用独立于PPAR:TR异二聚体的形成或对DNA结合的竞争。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验